ABE Australia Biotechnology Express NMN 16000

Visão geral do produto

About ABE Australia Biotechnology Express NMN 16000

ABE Australia Biotechnology Express NMN 16000 is identified as a medicine. The supplied product information lists a combination of active ingredients, including nicotinamide mononucleotide, heavy magnesium oxide, chromium picolinate, nicotinic acid, Curcuma longa, cyanocobalamin, nicotinamide, leucine, riboflavin, Centipeda cunninghamii, ubidecarenone, folic acid, quercetin, Piper nigrum, Biotin, and T. No inactive ingredients, dosage information, approved indications, or additional product notes were provided.

Key Benefits & Uses

• Contains nicotinamide mononucleotide and the other active ingredients listed for this formulation.
• Is presented as a medicine under the name ABE Australia Biotechnology Express NMN 16000.
• Specific benefits, therapeutic uses, and intended patient groups are not stated in the supplied information.

Active Ingredient & Action

The listed active ingredients are heavy magnesium oxide, chromium picolinate, nicotinic acid, Curcuma longa, cyanocobalamin, nicotinamide mononucleotide, Biotin, nicotinamide, leucine, riboflavin, Centipeda cunninghamii, ubidecarenone, folic acid, quercetin, Piper nigrum, and T. The available facts do not specify the amount, formulation, or action of any ingredient.

Important Notes

Read the product packaging or official prescribing information for directions, dosage, warnings, contraindications, interactions, and storage requirements. These details were not supplied for this description. No inactive ingredients or side-effect information were provided.